Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05645510 | LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study(LONGEVITI) | recruiting | — | 75 | University of AlbertaOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT04035642 | Single-Dose Image-Guided Radiotherapy With Urethral Sparing and DIL Boost for Intermediate-Risk Prostate Cancer (PROSINT II)(PROSINT II) | recruiting | N/A | 200 | Fundacao ChampalimaudOTHER | 1 | May 8, 2026 |
| clinicaltrials |
| NCT04986423 | ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 2 | 200 | Zenith EpigeneticsINDUSTRY | 2 | May 8, 2026 | clinicaltrials |
| NCT06011499 | Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE(iLIVE) | recruiting | N/A | 250 | OHSU Knight Cancer InstituteOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07384416 | QL1706 Plus Lenvatinib in Previously Treated Penile Cancer | recruiting | Phase 2 | 47 | Sun Yat-sen UniversityOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT07414940 | ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium(ACT-RESoLUTE) | recruiting | Phase 1 / Phase 2 | 60 | University College, LondonOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT03880422 | Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer | recruiting | N/A | 50 | Roswell Park Cancer InstituteOTHER | 1 | May 7, 2026 | clinicaltrials |
| NCT03819101 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer(PEACE-4) | recruiting | Phase 3 | 1,210 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 6 | May 6, 2026 | clinicaltrials |
| NCT06239194 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 285 | ModeX Therapeutics, An OPKO Health CompanyINDUSTRY | 1 | May 6, 2026 | clinicaltrials |
| NCT07504835 | GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer | recruiting | N/A | 150 | OHSU Knight Cancer InstituteOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT07568613 | Comparing PSMA PET/CT and MRI-RSI for Finding and Outlining Tumors Inside the Prostate in Men With Newly Diagnosed Prostate Cancer(PRIDE2-PC) | recruiting | N/A | 50 | German Oncology Center, CyprusOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT05125016 | A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate Cancer | recruiting | Phase 1 / Phase 2 | 228 | Regeneron PharmaceuticalsINDUSTRY | 1 | May 5, 2026 | clinicaltrials |
| NCT06616155 | Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 / Phase 2 | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT07354919 | Axelopran for Advanced Cancer in Patients Receiving Opioids(AxeCan) | recruiting | Phase 2 | 34 | HealthPartners InstituteOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT05948657 | Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr(ESCAPE) | recruiting | N/A | 200 | Weill Medical College of Cornell UniversityOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06193369 | Digital Peer Navigation for Adolescents and Young Adults With Cancer | recruiting | N/A | 138 | University Health Network, TorontoOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06429813 | Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006) | recruiting | N/A | 24 | Paul ViscuseOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT06773806 | CHLORDECONE EXPOSURE AND PROSTATE CANCER IN THE FRENCH REGION OF MARTINIIQUE(CHLOECAPA) | recruiting | — | 3,600 | Institut National de la Santé Et de la Recherche Médicale, FranceOTHER_GOV | 1 | May 4, 2026 | clinicaltrials |
| NCT03067051 | Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System | recruiting | Phase 1 / Phase 2 | 66 | SpectraCure ABINDUSTRY | 4 | May 1, 2026 | clinicaltrials |
| NCT06807359 | Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System | recruiting | Phase 1 / Phase 2 | 43 | SpectraCure ABINDUSTRY | 2 | May 1, 2026 | clinicaltrials |
| NCT07562438 | Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 2 | 20 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | May 1, 2026 | clinicaltrials |
| NCT02526368 | Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer | recruiting | Early Phase 1 | 80 | Ivan de Kouchkovsky, MDOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07451795 | SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC(SHARP) | recruiting | Phase 2 | 66 | Fudan UniversityOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT07559201 | Theranostic Applications of Radionuclides in Prostate Cancer | recruiting | N/A | 100 | Guilin Medical University, ChinaOTHER | 1 | Apr 30, 2026 | clinicaltrials |
| NCT06914544 | Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)(HYPOSTAT-III) | recruiting | N/A | 175 | University Hospital Schleswig-HolsteinOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT06363435 | AI-based Measurements of Tumour Burden in PSMA PET-CT | recruiting | — | 1,500 | Elin TragardhOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT07553754 | Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis(EXO-MET) | recruiting | — | 1,000 | Xijing HospitalOTHER | 1 | Apr 28, 2026 | clinicaltrials |
| NCT06242509 | Intestinal Akkermansia Muciniphila in Prostate Cancer(AkkPRO) | recruiting | — | 52 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT07552285 | The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center | recruiting | — | 300 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT07552922 | Determining INdividual Preferences for Gynecomastia avOidance (DINGO) - Stage 1(DINGO) | recruiting | N/A | 24 | St Vincent's Hospital, SydneyOTHER | 1 | Apr 27, 2026 | clinicaltrials |
| NCT06594926 | Working Out M0 Bipolar Androgen Therapy(WOMBAT) | recruiting | Phase 2 | 69 | Australian and New Zealand Urogenital and Prostate Cancer Trials GroupOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT03522064 | Bipolar Androgen Therapy + Carboplatin in mCRPC(HiTeCH) | recruiting | Phase 2 | 30 | St Vincent's Hospital, SydneyOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT06487507 | Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS) | recruiting | N/A | 20 | University of MiamiOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT07004582 | Lab Research Using Mini-tumors to Study Prostate Cancer Treatments(PR3DICT) | recruiting | — | 600 | Maastricht Radiation OncologyOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT05155501 | Clinical Trial of Approaches to Prostate Cancer Surgery(PARTIAL) | recruiting | N/A | 600 | Weill Medical College of Cornell UniversityOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT06172283 | Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy | recruiting | N/A | 30 | State University of New York at BuffaloOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT04638088 | Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy(EMUPRO) | recruiting | — | 2,000 | ElsanOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT04946370 | Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer | recruiting | Phase 1 / Phase 2 | 52 | Weill Medical College of Cornell UniversityOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT07407283 | A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer | recruiting | Phase 1 / Phase 2 | 100 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Apr 21, 2026 | clinicaltrials |
| NCT05969860 | At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer | recruiting | Phase 2 | 220 | Mayo ClinicOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT07219147 | 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 | 30 | City of Hope Medical CenterOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT05478694 | Outcomes of Focal Ablation for Prostate Cancer | recruiting | — | 225 | University of Texas Southwestern Medical CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07218913 | Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors | recruiting | Phase 1 | 44 | City of Hope Medical CenterOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07484971 | Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria(CLIQQC) | recruiting | — | 2,000 | Société Algérienne de Formation et Recherche en OncologieOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT07537010 | 3D1015 Injection for Patients With mCRPC | recruiting | Phase 1 | 8 | Chunjing YuOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT03620786 | HIFU for Focal Ablation of Prostate Tissue: An Observational Study | recruiting | — | 100 | University of California, Los AngelesOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT05497024 | Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing | recruiting | — | 45 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT06171139 | Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer | recruiting | N/A | 80 | University of California, San FranciscoOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT06347705 | A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer | recruiting | Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT06439225 | Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes(OPTION-DDR) | recruiting | Phase 3 | 236 | Canadian Cancer Trials GroupNETWORK | 1 | Apr 16, 2026 | clinicaltrials |
Data updated 23 days agoSource updated May 11, 2026source: clinicaltrials